BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17867325)

  • 1. [Cervical cancer screening in Poland and worldwide].
    Spaczyński M; Nowak-Markwitz E; Kedzia W
    Ginekol Pol; 2007 May; 78(5):354-60. PubMed ID: 17867325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimated results of prophylactic physical examinations detecting cervical cancer in Center of Oncology in Bydgoszcz in years 2001-2003].
    Mierzwa T; Grabiec M; Walentowicz M
    Ginekol Pol; 2005 Sep; 76(9):693-8. PubMed ID: 16417080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for application of molecular tests identyfying HR HPV DNA in the prevention of cervical cancer. Statement of experts from PGS (PTG) and NCLD (KIDL)].
    ;
    Ginekol Pol; 2013 May; 84(5):395-9. PubMed ID: 23819408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactics of cervical cancer in Polish female population aged 45-54].
    Bińkowska M; Debski R
    Ginekol Pol; 2005 Nov; 76(11):863-70. PubMed ID: 16566360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cervical cancer in Poland and in the world--in the light of incidence and mortality data].
    Nowakowski AM; Kotarski J
    Przegl Epidemiol; 2011; 65(1):75-9. PubMed ID: 21735841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic medical investigations for breast cancer and uterine cervix cancer in Regional Oncology Centre of Bydgoszcz in 2003].
    Mierzwa T; Grabiec M
    Wiad Lek; 2004; 57 Suppl 1():207-10. PubMed ID: 15884240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening and updated Pap guidelines.
    Warren JB; Gullett H; King VJ
    Prim Care; 2009 Mar; 36(1):131-49, ix. PubMed ID: 19231606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of screening program for cervical cancer in Lodz].
    Gottwald L; Giernat L; Lech W; Wójcik-Krowiranda K; Akoel KM; Kowalczyk-Amico K; Estemberg D; Grzesiak M; Sosnowski D; Guzowski G; Baś E; Tyliński W; Bieńkiewicz A
    Ginekol Pol; 2002 Nov; 73(11):934-8. PubMed ID: 12722377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Awareness of cervical cancer prevention among patients of gynecological outpatient clinic].
    Ulman-Włodarz I; Nowosielski K; Romanik M; Pozowski J; Jurek M
    Ginekol Pol; 2011 Jan; 82(1):22-5. PubMed ID: 21473052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based, alternative cervical cancer screening approaches in low-resource settings.
    Sherris J; Wittet S; Kleine A; Sellors J; Luciani S; Sankaranarayanan R; Barone MA
    Int Perspect Sex Reprod Health; 2009 Sep; 35(3):147-54. PubMed ID: 19805020
    [No Abstract]   [Full Text] [Related]  

  • 11. Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device.
    Stenvall H; Wikström I; Backlund I; Wilander E
    Acta Obstet Gynecol Scand; 2007; 86(1):16-21. PubMed ID: 17230283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One Pap smear of benefit in developing countries.
    Bagchi S
    Lancet Oncol; 2005 Jan; 6(1):9. PubMed ID: 15672493
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of the Pap: where is cervical cancer screening headed?
    Ruhl C
    Nurs Womens Health; 2008 Oct; 12(5):427-31. PubMed ID: 18837722
    [No Abstract]   [Full Text] [Related]  

  • 14. Less frequent Pap smears for low-risk women?
    Sanders FN
    S Afr Med J; 2004 Jun; 94(6):435-6. PubMed ID: 15250453
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative analysis of abnormal Pap smear and the results of histopathological examination of specimens from the cervix of the programme in-depth diagnosis cervical cancer conducted at the of Operational Gynecology Department ICZMP in Lodz].
    Kulig B; Łukaszek S; Brucka A; Kałuzyński A; Kamer-Bartosińska A; Szyłło K
    Ginekol Pol; 2010 Nov; 81(11):828-33. PubMed ID: 21365898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
    Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
    BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
    Campos NG; Mvundura M; Jeronimo J; Holme F; Vodicka E; Kim JJ
    BMJ Open; 2017 Jun; 7(6):e015048. PubMed ID: 28619772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical screening.
    Rogers N
    Aust Fam Physician; 2007 May; 36(5):296. PubMed ID: 17542069
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
    Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
    Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.